NCT05644522Recruiting
Nomad P-KAFO Study
Power Forward Study: A Cross-Sector, Multisite Clinical Trial of a Powered Knee-Ankle-Foot Orthosis
Source: ClinicalTrials.gov · Last updated 11 May 2026
Brief summary (registry, in English)
The goal of this clinical trial is to evaluate the impact of using the Nomad powered KAFO in people who have had a musculoskeletal or neurological injury that has affected their ability to walk. The main questions it aims to answer are to quantify the effectiveness of the Nomad in improving mobility, balance, frequency of falls, and quality of life in individuals with lower-extremity impairments compared to their own brace, over three months of daily home and community use. Participants will: * Wear a sensor that records everyday activities and mobility. * Perform measures of mobility and different activities of participation using their own brace. * Perform measures of mobility and different activities of participation using the Nomad powered KAFO
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 36 (estimated)
- First submitted
- 28 Nov 2022
- Start date
- 1 Mar 2024
- Primary completion date
- Dec 2027
- Lead sponsor
- Shirley Ryan AbilityLab
- Diseases
- Stroke, Multiple sclerosis
- NCT number
- NCT05644522
What you commit to
- Study type: Interventional
- Planned participants: 36
- From 1 Mar 2024 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Flexion contracture in the knee and/or hip joint in excess of 15 degrees
- Non-correctable knee varus/valgus in excess of 15 degrees
- Severe spasticity
- Inability to stabilize the trunk with or without assistive devices (crutches, canes, etc.)
Who the study is looking for
- Regular and compliant use of a unilateral or bilateral KAFO or SCO or other passive KAFOs for impairment due to neurological or neuromuscular disease, orthopedic disease, or trauma
- Cognitive ability to understand and follow the study protocol; willingness to provide informed consent
- Willing to wear and charge an activity monitor for three-months home trials.
Age in the registry: 18 years to 89 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shirley Ryan AbilityLab Coordinator of this site? Confirm its status | Chicago | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.